Buy this Article for $7.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.


Alzheimer disease, dementia, cognitive decline



  1. Davis, Nicole J. MSN, GNP-BC, ANP-BC
  2. Hendrix, Cristina C. DNS, GNP-BC, FNP
  3. Superville, Jemma G. RN, MBA, MSN Ed, ANP, GNP


Alzheimer disease (AD) accounts for most dementia diagnoses. Acetylcholinesterase inhibitors and antipsychotics are first-line drug therapies for cognitive decline and to manage neuropsychiatric symptoms, respectively. Because AD is relentlessly progressive, NPs will need to provide long-term support to patients and their caregivers.